Why is Novartis India falling/rising?

As of 06-Nov, Novartis India Ltd is experiencing a decline in its stock price, currently at Rs 840.55, which reflects a decrease of Rs 17.5 or 2.04%. The stock has underperformed its sector by 1.27% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 3.71% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Over the past year, the stock has seen a significant decline of 22.19%, contrasting sharply with the Sensex, which has gained 3.65% in the same timeframe. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Novartis India's short-term performance has been notably weaker than the benchmark Sensex, which has only declined by 1.30% over the past week while Novartis has fallen by 2.54%. This underperformance is compounded by the stock's year-to-date decline of 8.62%, while the Sensex has risen by 6.62% during the same period. The rising investor participation, indicated by a 55.27% increase in delivery volume, suggests some interest in the stock, but it has not translated into positive price movement. Overall, the stock's current trajectory reflects a challenging environment both for the company and in comparison to the broader market.